The drugmaker has revamped how it packages, promotes and sells certain medicines in an effort to overcome a postpandemic ...

Pfizer’s CEO Albert Bourla has revamped sales tactics, leading to a 31% rise in U.S. sales of Nurtec migraine medication, reports The Wall Street Journal.

After learning doctors weren’t prescrbing its migraine drug Nurtec because they assumed insurance coverage would be a hassle, the company ...

Pfizer PFE1.28%increase; green up pointing triangle had a problem. Doctors weren’t prescribing its migraine drug Nurtec because they assumed insurance coverage would be too much of a hassle.

The massive pharmacy benefit manager plans to stop requiring coverage authorizations for roughly 80 drugs used to treat ...

Healthcare companies rose as traders sought out sectors that are less vulnerable to swings in economic growth and inflation prospects.

The drug is approved both to treat and prevent migraine in adults and is one of ... GlobalData said recently it expects Nurtec ODT to reach a peak of around $2 billion in annual sales in 2029 ...

Drug giant Pfizer is using doctor hotlines with advice on insurance coverage to drive sales of drugs such as migraine treatment Nurtec, The Wall Street Journal reported. Write to Rob Curran at rob ...

Atogepant was approved last September as Qulipta for migraine prevention in the US – where Vydura is known as Nurtec ODT and was cleared for acute migraine treatment in early 2020 and for ...

Taiwan Semiconductor Manufacturing, Salesforce, Oracle, Exxon Mobil, ServiceNow, D-Wave Quantum, and Pfizer are the seven Manufacturing stocks to watch today, according to MarketBeat’s stock screener ...